The management and outcome of propionic and methylmalonic acidaemia

Bain MD, 1994, Benefits of combining long term treatment strategies over a 13 year period in a patient with mut0 methylmalonic acidaemia

10.1203/00006450-199107000-00004

Baumgartner ER, 1994, Long term follow up of 75 patients with isolated methylmalonic (MMA) acidaemia

10.1007/BF02000791

10.1007/BF01955526

10.1016/S0022-3476(94)70364-7

10.1016/S0022-3476(88)80574-2

10.1016/S0022-3476(94)70311-6

10.1073/pnas.83.13.4864

10.1006/geno.1994.1099

10.1007/BF02138782

Losty HC, 1994, Secondary hyperparathyroidism — a new complication of methylmalonic acidaemia

10.1007/BF01955907

McKiernan PJ, 1994, Propionic acidaemia: partial correction by liver transplantation

10.1016/0888-7543(90)90259-W

10.3109/00365549409008599

10.1172/JCI111387

10.1007/BF01232647

10.1093/ajcn/59.6.1332

Snyderman SE, 1972, The use of neomycin in the treatment of methylmalonic acidemia, Pediatrics, 50, 925, 10.1542/peds.50.6.925

Stanley CA, 1987, New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency, Adv Paediatr, 34, 59

10.1016/0887-8994(92)90085-D

10.1007/BF01957284

10.1016/0026-0495(90)90084-P

10.1016/S0022-3476(05)82005-0

10.1007/BF00444131

10.1016/S0140-6736(89)92689-5

10.1203/00006450-199104000-00015

Wendel U, 1994, Odd numbered fatty acids (OLCFA) in patients treated for propionic (PA) and methylmalonic (MMA) acidaemias